Overview
Overcome Barriers to Adopting Dosimetry in Radiopharmaceutical Therapies
Logistical difficulties and concern about patient burden are common obstacles to implementing dosimetry in radiopharmaceutical therapy.
In this case study, Dr. Michael A. Morris shows how his clinic uses MIM SurePlan™ MRT and collaborative decision-making with patients to make dosimetry a routine part of its practice.
Watch the case study to see:
- Why dosimetry is important for personalized radiopharmaceutical therapy treatments.
- How a clinic makes dosimetry part of its Theranostics clinical routine.
- How dosimetry was critical in a neuroendocrine tumor 177Lu-DOTATATE case where renal function was a concern.
“If we retreat a patient and we don't know the dose that they received from their prior treatment ... we're really just guessing.”
Dr. Michael A. Morris
Founder & Medical Director | Advanced Molecular Imaging & Therapy
